312 related articles for article (PubMed ID: 28288718)
41. Comparative study of marginal zone lymphoma involving bone marrow.
Kent SA; Variakojis D; Peterson LC
Am J Clin Pathol; 2002 May; 117(5):698-708. PubMed ID: 12090417
[TBL] [Abstract][Full Text] [Related]
42. Splenic marginal zone lymphoma.
Dogan A; Isaacson PG
Semin Diagn Pathol; 2003 May; 20(2):121-7. PubMed ID: 12945935
[TBL] [Abstract][Full Text] [Related]
43. Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5' non-coding region of the bcl-6 gene.
Mateo MS; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
Leukemia; 2001 Apr; 15(4):628-34. PubMed ID: 11368366
[TBL] [Abstract][Full Text] [Related]
44. Exome sequencing identifies recurrent
Jallades L; Baseggio L; Sujobert P; Huet S; Chabane K; Callet-Bauchu E; Verney A; Hayette S; Desvignes JP; Salgado D; Levy N; Béroud C; Felman P; Berger F; Magaud JP; Genestier L; Salles G; Traverse-Glehen A
Haematologica; 2017 Oct; 102(10):1758-1766. PubMed ID: 28751561
[TBL] [Abstract][Full Text] [Related]
45. Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas.
Robledo C; García JL; Benito R; Flores T; Mollejo M; Martínez-Climent JÁ; García E; Gutiérrez NC; Piris MA; Hernández JM
PLoS One; 2011; 6(9):e24939. PubMed ID: 21957467
[TBL] [Abstract][Full Text] [Related]
46. Role of blood and bone marrow examination in the diagnosis of mature lymphoid neoplasms in patients presenting with isolated splenomegaly.
Sreedharanunni S; Sachdeva MU; Malhotra P; Ahluwalia J; Naseem S; Prakash G; Khadwal A; Sharma P; Kumar N; Varma N; Varma S; Das R
Hematology; 2015 Oct; 20(9):530-7. PubMed ID: 25760312
[TBL] [Abstract][Full Text] [Related]
47. Splenic marginal zone lymphoma: current knowledge and future directions.
Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
[TBL] [Abstract][Full Text] [Related]
48. Splenic marginal-zone lymphoma: ontogeny and genetics.
Baliakas P; Strefford JC; Bikos V; Parry M; Stamatopoulos K; Oscier D
Leuk Lymphoma; 2015 Feb; 56(2):301-10. PubMed ID: 24798744
[TBL] [Abstract][Full Text] [Related]
49. Idelalisib and Rituximab in 17p Deletion-Positive Splenic Marginal Zone Lymphoma.
Philip AZ
J Natl Compr Canc Netw; 2018 Mar; 16(3):230-233. PubMed ID: 29523661
[TBL] [Abstract][Full Text] [Related]
50. Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.
Traverse-Glehen A; Bachy E; Baseggio L; Callet-Bauchu E; Gazzo S; Verney A; Hayette S; Jallades L; Ffrench M; Salles G; Coiffier B; Felman P; Berger F
Histopathology; 2013 May; 62(6):876-93. PubMed ID: 23611359
[TBL] [Abstract][Full Text] [Related]
51. Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases.
Mollejo M; Menárguez J; Lloret E; Sánchez A; Campo E; Algara P; Cristóbal E; Sánchez E; Piris MA
Am J Surg Pathol; 1995 Oct; 19(10):1146-57. PubMed ID: 7573673
[TBL] [Abstract][Full Text] [Related]
52. Splenic marginal zone lymphoma: disease features and management.
Matutes E
Expert Rev Hematol; 2013 Dec; 6(6):735-45. PubMed ID: 24168526
[TBL] [Abstract][Full Text] [Related]
53. Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas.
Sol Mateo M; Mollejo M; Villuendas R; Algara P; Sánchez-Beato M; Martinez-Delgado B; Martínez P; Piris MA
Mol Pathol; 1998 Oct; 51(5):262-7. PubMed ID: 10193520
[TBL] [Abstract][Full Text] [Related]
54. FOXP1 status in splenic marginal zone lymphoma: a fluorescence in situ hybridization and immunohistochemistry approach.
Baró C; Espinet B; Salido M; Colomo L; Luño E; Florensa L; Ferrer A; Salar A; Campo E; Serrano S; Solé F
Histol Histopathol; 2009 Nov; 24(11):1399-404. PubMed ID: 19760589
[TBL] [Abstract][Full Text] [Related]
55. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
[TBL] [Abstract][Full Text] [Related]
56. Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes.
Vega F; Cho-Vega JH; Lennon PA; Luthra MG; Bailey J; Breeden M; Jones D; Medeiros LJ; Luthra R
Br J Haematol; 2008 Jun; 142(2):216-26. PubMed ID: 18492102
[TBL] [Abstract][Full Text] [Related]
57. Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma.
Catovsky D; Matutes E
Semin Hematol; 1999 Apr; 36(2):148-54. PubMed ID: 10319383
[TBL] [Abstract][Full Text] [Related]
58. Tissue proteomics of splenic marginal zone lymphoma.
Polati R; Brandi J; Dalai I; Zamò A; Cecconi D
Electrophoresis; 2015 Jul; 36(14):1612-21. PubMed ID: 25873066
[TBL] [Abstract][Full Text] [Related]
59. Absence of cyclin D1 protein expression in splenic marginal zone lymphoma.
Savilo E; Campo E; Mollejo M; Pinyol M; Piris MA; Zukerberg LR; Yang WI; Koelliker DD; Nguyen PL; Harris NL
Mod Pathol; 1998 Jul; 11(7):601-6. PubMed ID: 9688179
[TBL] [Abstract][Full Text] [Related]
60. Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss in 7q31-32.
Boonstra R; Bosga-Bouwer A; van Imhoff GW; Krause V; Palmer M; Coupland RW; Dabbagh L; van den Berg E; van den Berg A; Poppema S
Mod Pathol; 2003 Dec; 16(12):1210-7. PubMed ID: 14681321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
